PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7283386

Leprosy.

T Tan
View original source ↗Export metadata ↓

Abstract

Leprosy is still a medical problem in the tropical and subtropical countries in Africa, Asia and South and Central America. New evidence on the airborne transmission of the disease is presented. The rest of the review deals with the clinical manifestations, the use of anti-leprosy drugs, and the treatment of reactions. Prophylaxis by BCG and chemoprophylaxis are briefly discussed.

Explore related subjects

BCG VaccineGlobal HealthHost-Parasite InteractionsHumansLeprostatic AgentsLeprosyJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T Tan. 1981. Leprosy.. https://pubmed.ncbi.nlm.nih.gov/7283386/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

Tuberculosis and cancer: parallels in host responses and therapeutic approaches?

Mycobacteria elicit two quite different immune responses. One is protective and is partly based on recognition and lysis of stressed, bacilli-laden cells expressing heat-shock proteins. The other suppresses this recognition and instead leads to indiscriminate necrosis of tissues containing mycobacteria (the Koch phenomenon). The type of response depends on the predominant T-cell maturation pathway, Th1 or Th2, which in turn is determined by priming by prior contact with environmental mycobacteria. Vaccination by BCG induces whichever response the recipient is primed to make, and this is a likely explanation of the variable efficacy of this vaccine in prevention of tuberculosis and therapy of cancer. Thus; BCG is a two-edged sword. We postulate that by using other mycobacterial preparations, such as killed Mycobacterium vaccae, it might be possible to suppress the indiscriminate necrosis and enhance Th1-regulated selective destruction of tumour cells.

BCG Vaccine↗